论文部分内容阅读
美国波士顿消息:据弗吉尼亚大学医学中心的初步研究称,一种治疗晚期妇科癌症的化疗和大剂量辐射联合新疗法,可延长存活时间和更好地控制局部病变。在美国治疗放射学和肿瘤学学会的会议上,治疗放射学副教授Ronald Kersh说,联合疗法显示出以下令人鼓舞的结果:对25名病人随访18～42个月(中间数为28个月),总存活率为56％。19名病人经5-氟尿嘧啶(5-FU)和丝裂霉素C以及放射治疗,14名病人存活。12人完全有效而且没有残存癌瘤的迹象,经治
Boston, United States: According to a preliminary study by the University of Virginia Medical Center, a combination of chemotherapy and high-dose radiation combined with new therapies for advanced gynecologic cancer can prolong survival and better control local lesions. At the American Society of Therapeutic Radiology and Oncology, Ronald Kersh, associate professor of therapeutic radiology, said that combination therapy showed encouraging results: follow-up of 25 patients for 18 to 42 months (median 28 months) The overall survival rate was 56%. Nineteen patients were treated with 5-fluorouracil (5-FU) and mitomycin C and radiotherapy, and 14 patients survived. 12 people are fully effective and there are no signs of residual cancer.